Change in the taste with the cancer chemotherapy and effort to zinc supplement

Change in the taste with the cancer chemotherapy and effort to zinc supplement - Chemotherapy and zinc supplement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034332

Enrollment

Registered

2018-10-01

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical oncology

Interventions

You take the dietary supplement which has strengthened the zinc (Arginaid Water), the taste ckeck using the taste disk and several nutritional index including the serum zinc value is examined in befo

t wish makes a dietary supplement the subject, too.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who newly introduces cancer chemotherapy by the surgery of Uwajima city hospital is subjected.

Exclusion criteria

Exclusion criteria: Patient with the taste obstacle Patient with cognitive disfunction

Design outcomes

Primary

Measure	Time frame
The change in the taste by the taste disk after 3 months chemotherapy and correlation with zinc supplement is considered.	—

Secondary

Measure	Time frame
Correlation between the zinc intake and the serum zinc value is considered Correlation between the taste obstacle and the serum zinc value is considered.	—

Countries

Japan

Contacts

Public ContactKenzo Okada

Uwajima City Hospital Department of Surgery

okada@uwajima-mh.jp0895-25-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026